Call Options

29 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$164.99 - $203.87 $7.66 Million - $9.46 Million
46,400 Added 33.5%
184,900 $32.9 Million
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $4.33 Million - $5.26 Million
26,400 Added 23.55%
138,500 $27.4 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $1.46 Million - $1.7 Million
9,400 Added 9.15%
112,100 $19.2 Million
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $41.6 Million - $47.4 Million
-260,400 Reduced 71.72%
102,700 $18.7 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $16.7 Million - $18.8 Million
121,100 Added 50.04%
363,100 $56.3 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $2.98 Million - $3.45 Million
22,300 Added 10.15%
242,000 $36.1 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $1.42 Million - $1.76 Million
10,700 Added 5.12%
219,700 $29.6 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $17.2 Million - $19.8 Million
119,000 Added 132.22%
209,000 $33.3 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $82,986 - $99,522
600 Added 0.67%
90,000 $14.6 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $617,366 - $708,078
4,600 Added 5.42%
89,400 $12 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $17.3 Million - $22 Million
-125,800 Reduced 59.73%
84,800 $13 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $21.7 Million - $26.9 Million
-164,100 Reduced 43.8%
210,600 $34.1 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $1.59 Million - $2.01 Million
14,800 Added 4.11%
374,700 $50.7 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $2.29 Million - $2.6 Million
-21,500 Reduced 5.64%
359,900 $38.8 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $9.22 Million - $10.3 Million
87,600 Added 29.82%
381,400 $43 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $838,860 - $923,484
-8,200 Reduced 2.72%
293,800 $31.8 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $9.81 Million - $13.2 Million
121,900 Added 67.68%
302,000 $32.4 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $3.02 Million - $3.55 Million
35,200 Added 24.29%
180,100 $15.8 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $7.54 Million - $10.1 Million
102,800 Added 244.18%
144,900 $14.2 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $8.05 Million - $12.2 Million
-124,800 Reduced 74.78%
42,100 $3.21 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $2.56 Million - $3.2 Million
35,500 Added 27.02%
166,900 $14.8 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $9.12 Million - $11 Million
-144,800 Reduced 52.43%
131,400 $9.95 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $11.3 Million - $14.4 Million
171,900 Added 164.81%
276,200 $20.1 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $4.89 Million - $5.76 Million
63,400 Added 155.01%
104,300 $8.41 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $591,660 - $729,676
7,600 Added 22.82%
40,900 $3.77 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $2.17 Million - $2.41 Million
24,400 Added 274.16%
33,300 $3.15 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $799,042 - $945,447
8,900 New
8,900 $825,000
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $850,820 - $932,994
-9,500 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $663,575 - $847,590
9,500
9,500 $843,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $374B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.